A Zullo, V De Francesco, C Hassan, S Morini, … - British Medical Journal, 2007 - gut.bmj.com Background:: Standard triple therapies are the most used treatment in clinical
practice. However, a critical fall in the H pylori eradication rate following
these therapies has been observed in the last few years. The sequential ... Cited by 41 - Related articles - BL Direct - All 5 versions
- ►annals.org [PDF] NS Jafri, CA Hornung, CW Howden - Annals of internal medicine, 2008 - Am Coll Physicians Page 1. Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy
for Helicobacter pylori Infection in Patients Naive to Treatment ... Cited by 35 - Related articles - BL Direct - All 6 versions
N Vakil, F Megraud - Gastroenterology, 2007 - Elsevier Helicobacter pylori is an organism that has had an intimate association with
mankind for many generations. Recent studies suggest that H pylori may have
spread from east Africa with human migration approximately 58,000 years ... Cited by 29 - Related articles - All 24 versions
S Shi, U Klotz - European Journal of Clinical Pharmacology, 2008 - Springer Abstract Background Proton pump inhibitors (PPIs) represent drugs of first
choice for treating peptic ulcer, Helicobacter pylori infection,
gastrooesophageal reflux disease, nonsteroidal anti-inflammatory drug ... Cited by 23 - Related articles - All 2 versions
DY Graham, A Shiotani - Nature Clinical Practice Gastroenterology and …, 2008 - members.medscape.com The prevalence of antimicrobial drug resistance is now so high that all patients
infected with Helicobacter pylori should be considered as having resistant
infections. Ideally, therapy should be based on pretreatment antibiotic- ... Cited by 21 - Related articles - BL Direct - All 9 versions
M Caselli, A Zullo, G Maconi, F Parente, V … - Digestive and Liver Disease, 2007 - Elsevier Proper management of Helicobacter pylori infection in clinical practice – when
supported by evidence-based data – is expected to produce substantial
cost-efficacy advantages. This consideration has prompted the Cervia ... Cited by 15 - Related articles - All 4 versions
P Moayyedi - The Lancet, 2007 - Elsevier Triple therapy with clarithromycin and proton-pump inhibitors (PPI) is the
recommended regimen for Helicobacter pylori eradication 1 in Europe, the USA,
and Canada. This treatment was first described by Italian researchers 2 and ... Cited by 12 - Related articles - All 13 versions
BJ Egan, M Katicic, HJ O'Connor, CA O' … - HELICOBACTER-CAMBRIDGE USA-, 2007 - sovegastro.com Abstract Since the discovery of Helicobacter pylori in the early 1980s many
treatment regimes have been developed to effectively treat this infection.
International guidelines have allowed consensus on the best management and ... Cited by 12 - Related articles - View as HTML - BL Direct - All 6 versions
F Perna, A Zullo, C Ricci, C Hassan, S Morini, … - Digestive and Liver Disease, 2007 - Elsevier Bacterial culture was available in 33 (82.5%) out 40 patients, and primary
levofloxacin resistance was detected in 10 (30.3%) patients. Overall, 33 of 40
patients accepted to participate in this study, and all returned for ... Cited by 10 - Related articles - All 12 versions
DY Graham, H Lu, Y Yamaoka - Helicobacter, 2007 - interscience.wiley.com Helicobacter pylori causes a serious bacterial infectious disease, and the
expectations of therapy should reflect this fact. Increasing antibiotic
resistance, especially to clarithromycin, has significantly undermined the ... Cited by 11 - Related articles - BL Direct - All 4 versions
